Next Article in Journal
Safety and Efficacy of Stroke Thrombolysis for Patients with Cerebral Cavernous Malformations: Literature Review and Nationwide Cohort Study
Previous Article in Journal
Disparities in Spinal Muscular Atrophy-Related Mortality in the United States, 2018–2023
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Inflammatory Mediators of Alzheimer’s Disease Characterized in a Mouse Model (APP/PS1)

by
Adrian Jorda
1,2,
Kenia Alvarez-Gamez
1,
Ignacio Campo-Palacio
1,
Juan Campos-Campos
1,2,
Carlos Colmena
1,
Sandeep Kumar Singh
3,
Maria Jose Chiva Miralles
2,
Constanza Aldasoro
1,
Martin Aldasoro
1 and
Soraya L. Valles
1,*
1
Department of Physiology, School of Medicine, University of Valencia, 46010 València, Spain
2
Faculty of Nursing and Podiatry, University of Valencia, 46010 València, Spain
3
Department of Medical Biotechnology, AIIMS, Nagpur 441108, MH, India
*
Author to whom correspondence should be addressed.
NeuroSci 2026, 7(1), 23; https://doi.org/10.3390/neurosci7010023
Submission received: 13 January 2026 / Revised: 28 January 2026 / Accepted: 4 February 2026 / Published: 6 February 2026

Abstract

Alzheimer’s disease (AD) is marked by amyloid plaques, hyperphosphorylated TAU proteins, and neuroinflammation. The APP/PS1 mouse model is widely used to study AD pathogenesis. In this study, we investigated the expression of chemokines and their receptors, which may play a role in AD’s pathological mechanisms, using brain cortex tissue from female APP/PS1 mice aged 20–21 months. We analyzed several chemokine receptors (CCR1, CCR2, CCR3, CCR4, CCR6, CCR7, CCR9, and CCR10) by Western blot and focused on CCR6, CCR7, and CCR10 using RT-PCR. Additionally, we quantified the levels of chemokines (CCL6, CCL8, CCL19, CCL20, CCL24, and CCL27) by RT-PCR. Our results showed a significant decrease in CCL8 and CCL19, along with their respective receptors, in the APP/PS1 mice compared to controls. On the other hand, we observed a notable increase in CCL6, CCL24, CCL20, CCL27, and their receptors. Chemokines like CCL8 and CCL20, involved in inflammatory responses, may reveal how neuroinflammation contributes to AD. CCL19 and CCL27 are linked to immune cell trafficking, which may help explain immune cell interactions with amyloid plaques and TAU tangles in the CNS. Overall, the altered expression of chemokines such as CCL24 could serve as biomarkers for early AD detection and monitoring disease progression. These findings suggest potential therapeutic targets to modulate immune responses and reduce neuroinflammation in AD.
Keywords: Alzheimer; chemokines; inflammatory mediators; APP/PS1 Alzheimer; chemokines; inflammatory mediators; APP/PS1

Share and Cite

MDPI and ACS Style

Jorda, A.; Alvarez-Gamez, K.; Campo-Palacio, I.; Campos-Campos, J.; Colmena, C.; Singh, S.K.; Miralles, M.J.C.; Aldasoro, C.; Aldasoro, M.; Valles, S.L. Inflammatory Mediators of Alzheimer’s Disease Characterized in a Mouse Model (APP/PS1). NeuroSci 2026, 7, 23. https://doi.org/10.3390/neurosci7010023

AMA Style

Jorda A, Alvarez-Gamez K, Campo-Palacio I, Campos-Campos J, Colmena C, Singh SK, Miralles MJC, Aldasoro C, Aldasoro M, Valles SL. Inflammatory Mediators of Alzheimer’s Disease Characterized in a Mouse Model (APP/PS1). NeuroSci. 2026; 7(1):23. https://doi.org/10.3390/neurosci7010023

Chicago/Turabian Style

Jorda, Adrian, Kenia Alvarez-Gamez, Ignacio Campo-Palacio, Juan Campos-Campos, Carlos Colmena, Sandeep Kumar Singh, Maria Jose Chiva Miralles, Constanza Aldasoro, Martin Aldasoro, and Soraya L. Valles. 2026. "Inflammatory Mediators of Alzheimer’s Disease Characterized in a Mouse Model (APP/PS1)" NeuroSci 7, no. 1: 23. https://doi.org/10.3390/neurosci7010023

APA Style

Jorda, A., Alvarez-Gamez, K., Campo-Palacio, I., Campos-Campos, J., Colmena, C., Singh, S. K., Miralles, M. J. C., Aldasoro, C., Aldasoro, M., & Valles, S. L. (2026). Inflammatory Mediators of Alzheimer’s Disease Characterized in a Mouse Model (APP/PS1). NeuroSci, 7(1), 23. https://doi.org/10.3390/neurosci7010023

Article Metrics

Back to TopTop